Stocktoria
NATURES SUNSHINE PRODUCTS INC NATR
NATURES SUNSHINE PRODUCTS INC (NATR) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 5.37% (safety: no dividend). FY2025 revenue was $480.1M at a 4.1% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.87 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.384 |
| Retained earnings / assets | 0.295 |
| EBIT / assets | 0.095 |
| Equity / liabilities | 1.622 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| NATR | NATURES SUNSHINE PRODUCTS INC | 6/9 | 5.82 | 18.9 | +5.7% |
| TVTX | Travere Therapeutics, Inc. | 5/9 | -5.38 | — | +110.5% |
| ZLAB | Zai Lab Ltd | 3/9 | -3.61 | — | +15.3% |
| BBIO | BridgeBio Pharma, Inc. | 1/9 | -14.22 | — | +126.3% |
| MIRM | Mirum Pharmaceuticals, Inc. | 4/9 | 0.54 | — | +54.7% |
| HCM | HUTCHMED (China) Ltd | 4/9 | 6.45 | 31.3 | -13% |
| INVA | Innoviva, Inc. | 3/9 | 6.59 | — | +14.7% |
About NATURES SUNSHINE PRODUCTS INC
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate intestinal and digestive functions; personal care products for external use, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste, and skin cleanser. In addition, the company provides weight management products, such as meal replacements and products that increase caloric burn rate. It offers its products under the Nature's Sunshine and Synergy Worldwide brands through its network of independent consultants to customers. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
FAQ
Is NATR financially healthy?
NATURES SUNSHINE PRODUCTS INC's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does NATR pay a dividend, and is it safe?
Yes. NATURES SUNSHINE PRODUCTS INC pays a dividend yielding about 5.37% with a None payout ratio, rated “no dividend” for safety.
How profitable is NATR?
In FY2025, NATURES SUNSHINE PRODUCTS INC had a net margin of 4.1% and a return on equity of 12.1%.
Is NATR overvalued or undervalued?
NATURES SUNSHINE PRODUCTS INC trades at about 14.6× trailing earnings — below its 10-year norm (10-year range 11.1×–115.9×, median 23.8×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for NATR?
The average Wall-Street price target for NATURES SUNSHINE PRODUCTS INC is $35.00, about 125.7% above the recent price, from 2 analysts.
Is NATR a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on NATURES SUNSHINE PRODUCTS INC: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a P/E of about 18.9×, a dividend yield of 5.37%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.